The leading biotechnology conference in Switzerland connects over 650 senior executives from the life science industry: Biotech entrepreneurs, investors, researchers, analysts, political decision-makers and industry stakeholders from more than 20 countries.
An emphasis will lie on opportunities and synergies offered by the close collaboration of pharma and biotech. Platforms are provided to discuss new developments in research and development, production, data management, artificial intelligence, and innovative financing. Program highlights are the release of the Swiss Biotech Report, highlighting trends and facts of the Swiss biotech industry, and the celebration of the Swiss Biotech Success Stories’ laureates of 2019. Sessions on fostering closer cooperation between companies and investors, partnering talks in a private setting, discussions with experts on financing, presentations of emerging companies, combined with a high-traffic exhibition make the Swiss Biotech Day as multi-faceted as the nature of the life sciences industry.